SCHEMBL8335235

SCHEMBL8335235

CN=C(Nc1cccc(C)c1F)Nc1cccc2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.48
MEN1 O00255 6/20 0.48
RAB9A P51151 5/20 0.46
NPC1 O15118 4/20 0.46
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 4/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 2/20 0.44
TP53 P04637 1/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44
RELA Q04206 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9819817 0.74 NPC1 (0.57) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL8425970 0.71 ALDH1A1 (0.45) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL6720855 0.71 SIGMAR1 (0.44) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL9628907 0.67 SIGMAR1 (0.71) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL3679747 0.67 NPC1 (0.68) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL30260457 0.67 NPC1 (0.68) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL17724353 0.66 ALDH1A1 (0.66) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL10577866 0.66 KDM4E (0.51) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL30323639 0.66 KDM4E (0.51) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL15856404 0.66 CYP2A6 (0.58) ALDH1A1KDM4EHPGDCYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999002145-A1 COMBINATION DRUG THERAPIES COMPRISING AMINOGLYCOSIDE ANTIBIOTICS AND N,N'-DISUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1999-01-21 WO disclosed